FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085757312> ?p ?o ?g. }

• W2085757312 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCOne of the severest hurdles in cancer treatment is multidrug resistance (MDR), resulting from overexpression of drug transporters and/or deregulation of cellular signaling transduction. Persistent efforts have been made to find new agents and strategies to overcome MDR. MDR involves almost all clinically-used anticancer drugs with natural origins. In this study, however, we found that the natural product tanshinone-1 could circumvent MDR via reducing phospho-705-Stat3, potentiated by inhibiting secondary activation of signaling networks. Tanshinone-1 is a bioactive ingredient in traditional Chinese medicine that exhibits diverse biologic properties, including anticancer properties. Tanshinone-1 displayed equipotent or even more potent cytotoxicity in three MDR tumor cell lines than in their corresponding parental cell lines. Tanshinone-1 induced apoptosis of the MDR cells by activating the intrinsic apoptotic pathway via disturbing mitochondria membrane potential and eliciting the cleavage of caspase-9 and caspase-3. The killing of MDR cells by tanshinone-1 was independent of drug transporters, but correlated tightly with its decreasing phospho-705-Stat3, highly possibly via activating certain phosphatase(s). The expression of the target genes of Stat3 including Mcl-1, cyclin D1, cIAP-2 and c-myc, was downregulated by the treatment with tanshinone-1. Knockdown of stat3 expression with specific small interfering RNA led to reduced sensitivity of the tested MDR cells to tanshinone-1. Treatment with Na3VO4, a pan inhibitor of phosphatases, completely reversed tanshinone-1-induced decrease of phospho-705-Stat3 and significantly lowered its cytotoxicity. Knockdown of phosphatase SHP-2 or PTP1B prevented reduction of phospho-705-Stat3 and induction of cell apoptosis driven by tanshinone-1. Further investigation revealed that tanshinone-1 activated signaling networks involving Akt, p38 and Erk pathways, possibly secondary to its reducing phospho-705-Stat3. Notably, simultaneous suppression of those pathways enhanced the cytotoxic effect of tanshinone-1 against the tested MDR cells. Cotreatment of the PI3K inhibitor PI103, the p38 inhibitor SB203580 and/or the MEK inhibitor AZD6244 with tanshinone-1 potentiated its apoptotic induction. However, PI103 and SB580203 appeared to show more potent synergism than AZD6244 when combined with tanshinone-1. Together, this study presents tanshinone-1 as an MDR-overcoming natural product, and more importantly, from our results, a therapeutic strategy of targeting signaling network(s) may evolve for MDR cancer therapy.Citation Format: Lei Xu, Jian-Ming Feng, Jia-Xin Li, Jin-Mei Zhu, Shan-Shan Song, Lin-Jiang Tong, Yi Chen, Fu-Lin Lian, Dong-Hai Lin, Jian Ding, Ze-Hong Miao. Tanshinone-1 kills multidrug resistant tumor cells via reducing phospho-705-Stat3, potentiated by inhibiting secondary activation of signaling networks. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 878. doi:10.1158/1538-7445.AM2013-878" @default.
• W2085757312 created "2016-06-24" @default.
• W2085757312 creator A5003323399 @default.
• W2085757312 creator A5013917173 @default.
• W2085757312 creator A5017061461 @default.
• W2085757312 creator A5028406995 @default.
• W2085757312 creator A5035644244 @default.
• W2085757312 creator A5046002874 @default.
• W2085757312 creator A5048910800 @default.
• W2085757312 creator A5061654403 @default.
• W2085757312 creator A5063800558 @default.
• W2085757312 creator A5076615377 @default.
• W2085757312 creator A5089348951 @default.
• W2085757312 date "2013-04-15" @default.
• W2085757312 modified "2023-09-22" @default.
• W2085757312 title "Abstract 878: Tanshinone-1 kills multidrug resistant tumor cells via reducing phospho-705-Stat3, potentiated by inhibiting secondary activation of signaling networks." @default.
• W2085757312 doi "https://doi.org/10.1158/1538-7445.am2013-878" @default.
• W2085757312 hasPublicationYear "2013" @default.
• W2085757312 type Work @default.
• W2085757312 sameAs 2085757312 @default.
• W2085757312 citedByCount "0" @default.
• W2085757312 crossrefType "proceedings-article" @default.
• W2085757312 hasAuthorship W2085757312A5003323399 @default.
• W2085757312 hasAuthorship W2085757312A5013917173 @default.
• W2085757312 hasAuthorship W2085757312A5017061461 @default.
• W2085757312 hasAuthorship W2085757312A5028406995 @default.
• W2085757312 hasAuthorship W2085757312A5035644244 @default.
• W2085757312 hasAuthorship W2085757312A5046002874 @default.
• W2085757312 hasAuthorship W2085757312A5048910800 @default.
• W2085757312 hasAuthorship W2085757312A5061654403 @default.
• W2085757312 hasAuthorship W2085757312A5063800558 @default.
• W2085757312 hasAuthorship W2085757312A5076615377 @default.
• W2085757312 hasAuthorship W2085757312A5089348951 @default.
• W2085757312 hasConcept C104317684 @default.
• W2085757312 hasConcept C121608353 @default.
• W2085757312 hasConcept C133936738 @default.
• W2085757312 hasConcept C173396325 @default.
• W2085757312 hasConcept C185592680 @default.
• W2085757312 hasConcept C190283241 @default.
• W2085757312 hasConcept C199835354 @default.
• W2085757312 hasConcept C22615655 @default.
• W2085757312 hasConcept C2775975398 @default.
• W2085757312 hasConcept C2778923194 @default.
• W2085757312 hasConcept C29537977 @default.
• W2085757312 hasConcept C501593827 @default.
• W2085757312 hasConcept C502942594 @default.
• W2085757312 hasConcept C54009773 @default.
• W2085757312 hasConcept C54355233 @default.
• W2085757312 hasConcept C55493867 @default.
• W2085757312 hasConcept C62478195 @default.
• W2085757312 hasConcept C81885089 @default.
• W2085757312 hasConcept C86803240 @default.
• W2085757312 hasConcept C96232424 @default.
• W2085757312 hasConcept C98274493 @default.
• W2085757312 hasConceptScore W2085757312C104317684 @default.
• W2085757312 hasConceptScore W2085757312C121608353 @default.
• W2085757312 hasConceptScore W2085757312C133936738 @default.
• W2085757312 hasConceptScore W2085757312C173396325 @default.
• W2085757312 hasConceptScore W2085757312C185592680 @default.
• W2085757312 hasConceptScore W2085757312C190283241 @default.
• W2085757312 hasConceptScore W2085757312C199835354 @default.
• W2085757312 hasConceptScore W2085757312C22615655 @default.
• W2085757312 hasConceptScore W2085757312C2775975398 @default.
• W2085757312 hasConceptScore W2085757312C2778923194 @default.
• W2085757312 hasConceptScore W2085757312C29537977 @default.
• W2085757312 hasConceptScore W2085757312C501593827 @default.
• W2085757312 hasConceptScore W2085757312C502942594 @default.
• W2085757312 hasConceptScore W2085757312C54009773 @default.
• W2085757312 hasConceptScore W2085757312C54355233 @default.
• W2085757312 hasConceptScore W2085757312C55493867 @default.
• W2085757312 hasConceptScore W2085757312C62478195 @default.
• W2085757312 hasConceptScore W2085757312C81885089 @default.
• W2085757312 hasConceptScore W2085757312C86803240 @default.
• W2085757312 hasConceptScore W2085757312C96232424 @default.
• W2085757312 hasConceptScore W2085757312C98274493 @default.
• W2085757312 hasLocation W20857573121 @default.
• W2085757312 hasOpenAccess W2085757312 @default.
• W2085757312 hasPrimaryLocation W20857573121 @default.
• W2085757312 hasRelatedWork W1523740164 @default.
• W2085757312 hasRelatedWork W1974258053 @default.
• W2085757312 hasRelatedWork W1986806498 @default.
• W2085757312 hasRelatedWork W1988169558 @default.
• W2085757312 hasRelatedWork W2006228964 @default.
• W2085757312 hasRelatedWork W2007453791 @default.
• W2085757312 hasRelatedWork W2056318761 @default.
• W2085757312 hasRelatedWork W2077442045 @default.
• W2085757312 hasRelatedWork W2161954129 @default.
• W2085757312 hasRelatedWork W2299908333 @default.
• W2085757312 hasRelatedWork W2339625610 @default.
• W2085757312 hasRelatedWork W2399132476 @default.
• W2085757312 hasRelatedWork W2477027776 @default.
• W2085757312 hasRelatedWork W2740208605 @default.
• W2085757312 hasRelatedWork W2751845857 @default.
• W2085757312 hasRelatedWork W2793518816 @default.
• W2085757312 hasRelatedWork W2806250050 @default.
• W2085757312 hasRelatedWork W2944692855 @default.
• W2085757312 hasRelatedWork W2955107777 @default.
• W2085757312 hasRelatedWork W913477751 @default.
• W2085757312 isParatext "false" @default.
• W2085757312 isRetracted "false" @default.

• next